Cramer Says JPMorgan Is on Track to Become a $1 Trillion Giant

​JPMorgan Leads the Trillion-Dollar Race
Jim Cramer believes JPMorgan Chase could soon join the trillion-dollar club — and he’s betting on it. The “Mad Money” host reviewed six major U.S. companies valued between $500 billion and $1 trillion, ranking JPMorgan as the top contender to cross the milestone next.

“The reason I have JPMorgan as the favorite in this race, with three-to-one odds, is simple: the banks are on fire right now, and the stock is ridiculously cheap,” Cramer said. At about 15 times this year’s earnings, JPMorgan could reach $1 trillion “in a heartbeat” if investors start valuing it at even a slightly higher multiple.

Currently worth over $836 billion, JPMorgan remains the nation’s largest bank, praised for its “fortress balance sheet” and disciplined leadership under CEO Jamie Dimon. Cramer highlighted how the bank has thrived even during volatile markets, saying its ability to “consolidate in times of stress” sets it apart from rivals.

Oracle and Walmart Trail Close Behind
Cramer ranked Oracle as his second-most likely company to reach the trillion mark, crediting the software giant’s explosive growth from the AI boom. The stock has soared over 200% in three years, driven by its role as a key supplier of cloud services to major AI firms — including its massive $300 billion deal with OpenAI.

Still, Cramer voiced caution. “No one needs OpenAI to come through quite like Oracle does,” he said, pointing to the company’s heavy reliance on the partnership to sustain growth.

In third place was Walmart, valued around $833 billion. The retail titan’s scale, supply-chain dominance, and resilience against tariffs make it a strong long-term pick, though its valuation is already steep for a retailer. “It’s run a huge rally,” Cramer said, “but it’s earned it.”

Eli Lilly, Visa, and Mastercard Round Out the List
Coming in fourth, Eli Lilly remains the most valuable healthcare company globally, with a market cap near $782 billion. Its blockbuster GLP-1 weight loss and diabetes drug has propelled its rise, though regulatory risks and new competition from Novo Nordisk have slowed momentum. Cramer said Lilly’s next big catalyst could come from an expanded FDA approval or a pill-based version of its hit drug.

Cramer’s fifth and sixth picks — Visa and Mastercard — might be long shots for the trillion-dollar title, but both remain strong performers. Visa, now worth about $670 billion, has delivered 17% average annual returns over the past decade. Cramer predicted that if the company keeps that pace, “Visa will be a trillionaire within three years — just not the first one there.”

The Takeaway
​Cramer’s message was clear: the trillion-dollar race isn’t just for Big Tech anymore. With banks rebounding, AI reshaping the software industry, and consumer demand steady, traditional players like JPMorgan and Walmart are stepping into the spotlight. “The beauty of this market,” he said, “is that the next trillion-dollar company doesn’t have to be a tech company — it just has to keep delivering.”